Molnupiravir for the treatment of COVID-19 in immunocompromised participants: efficacy, safety, and virology results from the phase 3 randomized, placebo-controlled MOVe-OUT trial
暂无分享,去创建一个
Shan-Chwen Chang | M. Ramgopal | P. Delobel | J. Flores | M. Brown | A. Williams-Diaz | I. Khaertynova | Amanda Paschke | J. Strizki | H. Shamsuddin | J. Grobler | D. Florescu | H. Wan | C. D. De Anda | Matthew G Johnson | Leon Fouche | Jiejun Du | Michelle L. Brown | Matthew G. Johnson